Fig. 1From: MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathwayMeCP2 expression in 5-FU-resistant GC cells. The mRNA (A, B) and protein (C, D) levels of MeCP2 in 5-FU-resistant GC cells (BGC-823/5-FU and SGC-7901/5-FU) vs. in regular GC cells (BGC-823 and SGC-7901). The expression of MeCP2 in GC and normal tissues by immunohistochemistry (E) and WB test (F)Back to article page